The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA.
Cell Death Dis
; 11(8): 701, 2020 08 24.
Article
in En
| MEDLINE
| ID: mdl-32839432
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
/
Sulfonamides
/
Bridged Bicyclo Compounds, Heterocyclic
/
Bortezomib
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cell Death Dis
Year:
2020
Type:
Article
Affiliation country:
Germany